This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hebert, D. Articles by Lam, J. Y.T. Search for Related Content PubMed PubMed Citation Articles by Hebert, D. Articles by Lam, J. Y.T.

(Circulation. 1997;95:1308-1313.)
© 1997 American Heart Association, Inc.

Articles

Persistent Inhibition of Platelets During Continuous Nitroglycerin Therapy Despite Hemodynamic Tolerance

Daniel Hebert, MSc; Jian-Xin Xiang, MD; Jules Y.T. Lam, MD

the Department of Medicine, Montreal Heart Institute, University of Montreal Medical School, Canada.

Correspondence to Jules Y.T. Lam, MD, Thrombosis and Atherosclerosis Laboratory, Montreal Heart Institute, 5000 Belanger St E, Montreal, Quebec H1T 1C8, Canada.

Background Nitroglycerin has been shown to possess antiplatelet properties in both animals and humans. Tolerance to the hemodynamic effects of nitroglycerin develops with continuous therapy, but it is unclear whether there is tolerance to its antiplatelet effect.

Methods and Results Tolerance to nitroglycerin was studied by exposing porcine aortic media to flowing arterial blood from control pigs (n=9) or pigs treated with continuous nitroglycerin patches (Nitro-dur, 0.8 mg/h; n=11) at a shear rate of 3397 s^-1 for 3 minutes. Relative to baseline, mean arterial pressure fell by 10% at 3 and 24 hours (P<.05) but returned to baseline at 48 hours of continuous nitroglycerin treatment, whereas no significant changes were observed in control animals. Autologous ⁵¹Cr-labeled platelet deposition (x10⁶/cm²) on the aortic media at baseline and 3, 24, and 48 hours remained stable in control animals, with mean values of 94.8±5.9, 89.4±8.3, 89.3±8.8, and 84.3±5.7, respectively. However, in pigs treated continuously with nitroglycerin for 48 hours, platelet deposition was reduced significantly at 3 (65.9±4.8), 24 (63.8±6.4), and 48 hours (56.5±7.3) of nitroglycerin treatment compared with baseline (93.1±3.6). Platelet aggregation induced by thrombin also decreased at 3 (12.4±1.3), 24 (12.6±1.7), and 48 hours (10.8±1.6) of nitroglycerin treatment compared with baseline (16.3±1.4) but remained unchanged in the control group. Also, nitroglycerin treatment increased intraplatelet cGMP at 3, 24, and 48 hours compared with baseline.

Conclusions This study demonstrates the persistent inhibition of platelet function and platelet deposition on an injured arterial wall by continuous nitroglycerin therapy despite hemodynamic tolerance.

Key Words: nitroglycerin • platelets • hemodynamics • vasodilation • thrombosis

This article has been cited by other articles:

				J.-P. Bin, A. Doctor, J. Lindner, E. M. Hendersen, D. E. Le, H. Leong-Poi, N. G. Fisher, J. Christiansen, and S. Kaul Effects of Nitroglycerin on Erythrocyte Rheology and Oxygen Unloading: Novel Role of S-Nitrosohemoglobin in Relieving Myocardial Ischemia Circulation, May 30, 2006; 113(21): 2502 - 2508. [Abstract] [Full Text] [PDF]

				D. Hebert and J. Y. T. Lam Nitroglycerin rebound associated with vascular, rather than platelet, hypersensitivity J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2311 - 2316. [Abstract] [Full Text] [PDF]

				A. Gries, C. Bode, K. Peter, A. Herr, H. Bohrer, J. Motsch, and E. Martin Inhaled Nitric Oxide Inhibits Human Platelet Aggregation, P-Selectin Expression, and Fibrinogen Binding In Vitro and In Vivo Circulation, April 21, 1998; 97(15): 1481 - 1487. [Abstract] [Full Text] [PDF]